Prudential Financial
ALXO icon

Prudential Financial’s ALX Oncology ALXO Stock Holding History

Prudential Financial’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,780
Closed -$103K – 2617
2023
Q1 		$103K Buy
22,780
+4,000
+21% +$30.3K ﹤0.01% 2451
2022
Q4 		$212K Sell
18,780
-13,800
-42% -$155K ﹤0.01% 2384
2022
Q3 		$312K Sell
32,580
-5,510
-14% -$64.2K ﹤0.01% 2285
2022
Q2 		$308K Buy
+38,090
New +$415K ﹤0.01% 2332
2021
Q4 		– Sell
-9,845
Closed -$727K – 2631
2021
Q3 		$727K Hold
9,845
– – ﹤0.01% 1973
2021
Q2 		$538K Sell
9,845
-7,380
-43% -$442K ﹤0.01% 2106
2021
Q1 		$1.27M Buy
17,225
+6,720
+64% +$529K ﹤0.01% 1702
2020
Q4 		$905K Buy
10,505
+335
+3% +$20.2K ﹤0.01% 1798
2020
Q3 		$384K Buy
+10,170
New +$400K ﹤0.01% 2061

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Prudential Financial's ALXO Position: Q2 2023 in Review

Prudential Financial sold out of ALX Oncology (ALXO) in Q2 2023, closing a stake of 22,780 shares — an estimated $103K sold.

Prudential Financial first reported a position in ALXO in Q3 2020 and held it in 9 quarters. The position peaked at $1.27M in Q1 2021. 75 funds tracked by Wall St. Rank hold ALXO as of Q2 2023.

  • Prudential Financial reported no remaining ALX Oncology position as of Q2 2023 after selling out during the quarter.
  • Prudential Financial sold 22,780 ALX Oncology shares in Q2 2023, an estimated $103K.
  • Prudential Financial first reported a position in ALX Oncology in Q3 2020 and held it in 9 quarters.
  • Prudential Financial's ALX Oncology position peaked at $1.27M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.